Different forms of semaglutide are approved for use in people with diabetes, or for weight loss in people who are significantly overweight
[2] [3] These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)with tirzepatide being a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
You will likely see noticeable improvements within weeks of starting treatment
GHK modulated an activity of both metalloproteinases and their inhibitors (TIMP-1 and TIMP-2), acting as a main regulator of wound healing and skin remodeling processes [7, 8]
Regulatory Support That Reduces Risk Our in-house regulatory team assists partners with product registration, dossier preparation, and compliance, ensuring faster time-to-market and smooth navigation of country-specific requirements - a key advantage in regions like LATAM and MENA markets, where processes are complex